Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health

ACS Omega

Volumn 5, Issue 20, 2020, Pages 11849-11872

  Salehi, Bahare ^a   Machin, Laura ^b   Monzote, Lianet ^c   Sharifi Rad, Javad ^d   Ezzat, Shahira M ^e,f   Salem, Mohamed A ^g   Merghany, Rana M ^h   El Mahdy, Nihal M ^f   Klllç, Ceyda Sibel ⁱ   Sytar, Oksana ^j,k   Sharifi Rad, Mehdi ^l   Sharopov, Farukh ^m   Martins, Natália ^n,o   Martorell, Miquel ^p   Cho, William C ^q  

^a BAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF HAVANA   (Cuba)

^c INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e CAIRO UNIVERSITY   (Egypt)

^f October University for Modern Sciences and Arts   (Egypt)

^g Menoufia University   (Egypt)

^h NATIONAL RESEARCH CENTRE   (Egypt)

ⁱ ANKARA UNIVERSITY   (Turkey)

^j TARAS SHEVCHENKO NATIONAL UNIVERSITY OF KYIV   (Ukraine)

^k SLOVAK UNIVERSITY OF AGRICULTURE IN NITRA   (Slovakia)

^l KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^m Avicenna Tajik State Medical University   (Tajikistan)

ⁿ University of Porto   (Portugal)

^o UNIVERSITY OF PORTO   (Portugal)

^p UNIVERSITY OF CONCEPCIÓN   (Chile)

^q QUEEN ELIZABETH HOSPITAL   (Hong Kong)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85085662281     PISSN: None     EISSN: 24701343     Source Type: Journal    
DOI: 10.1021/acsomega.0c01818     Document Type: Article

References (288)

1. Spencer, J. P.; Vauzour, D.; Rendeiro, C. Flavonoids and cognition: the molecular mechanisms underlying their behavioral effects. Arch. Biochem. Biophys. 2009, 492, 1-9, 10.1016/j.abb.2009.10.003
2. Kaşlkcl, M. B.; Baǧdatlloǧlu, N. Bioavailability of quercetin. Curr. Res. Nutr. Food Sci. 2016, 4, 146-151, 10.12944/CRNFSJ.4.Special-Issue-October.20
3. David, A. V. A.; Arulmoli, R.; Parasuraman, S. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn. Rev. 2016, 10, 84-89, 10.4103/0973-7847.194044
4. Sytar, O.; Kosyan, A.; Taran, N.; Smetanska, I. Anthocyanin's as marker for selection of buckwheat plants with high rutin content. Gesunde Pflanzen 2014, 66, 165, 10.1007/s10343-014-0331-z
5. Miles, S. L.; McFarland, M.; Niles, R. M. Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human diseases. Nutr. Rev. 2014, 72, 720-734, 10.1111/nure.12152
6. Guo, Y.; Bruno, R. S. Endogenous and exogenous mediators of quercetin bioavailability. J. Nutr. Biochem. 2015, 26, 201-210, 10.1016/j.jnutbio.2014.10.008
7. Russo, M.; Spangnulo, C.; Tedesco, I.; Bilotto, S.; Russo, G. L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 2012, 83, 6-15, 10.1016/j.bcp.2011.08.010
8. Sultana, B.; Anwar, F. Flavonols (kaempeferol, quercetin, myricetin) contents of selected fruits, vegetables and medicinal plants. Food Chem. 2008, 108, 879-888, 10.1016/j.foodchem.2007.11.053
9. Pérez-Jiménez, J.; Neveu, V.; Vos, F.; Scalbert, A. Identification of the 100 richest dietary sources of polyphenols: An application of the phenol-explorer database. Eur. J. Clin. Nutr. 2010, 64, S112-S120, 10.1038/ejcn.2010.221
10. Dinelli, G.; Bonetti, A.; Minelli, M.; Marotti, I.; Catizone, P.; Mazzanti, A. Content of flavonols in Italian bean (Phaseolus vulgaris L.) ecotypes. Food Chem. 2006, 99, 105-114, 10.1016/j.foodchem.2005.07.028
11. Sytar, O.; Bruckova, K.; Hunkova, E.; Zivcak, M.; Konate, K.; Brestic, M. The application of muliplex flourimetric sensor for analysis flavonoids content in the medical herbs family Asteraceae, Lamiaceae, Rosaceae. Biol. Res. 2015, 48, 5, 10.1186/0717-6287-48-5
12. Sokól-Lȩtowska, A.; Osmianski, J.; Wojdylo, A. Antioxidant activity of phenolic compounds of hawthorn, pine and skullcap. Food Chem. 2007, 103, 853-859, 10.1016/j.foodchem.2006.09.036
13. Haenen, G. R.; Paquay, J. B.; Korthouwer, R. E.; Bast, A. Peroxynitrite scavenging by flavonoids. Biochem. Biophys. Res. Commun. 1997, 236, 591-593, 10.1006/bbrc.1997.7016
14. Dell'Albani, P.; Di Marco, B.; Grasso, S.; Rocco, C.; Foti, M. C. Quercetin derivatives as potent inducers of selective cytotoxicity in glioma cells. Eur. J. Pharm. Sci. 2017, 101, 56-65, 10.1016/j.ejps.2017.01.036
15. Mouradov, A.; Spangenberg, G. Flavonoids: a metabolic network mediating plants adaptation to their real estate. Front. Plant Sci. 2014, 5, 620, 10.3389/fpls.2014.00620
16. Jacobs, M.; Rubery, P. H. Naturally occurring auxin transport regulators. Science 1988, 241, 346-349, 10.1126/science.241.4863.346
17. Dajas, F. Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012, 143, 383-396, 10.1016/j.jep.2012.07.005
18. Chirumbolo, S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function. Inflammation Allergy: Drug Targets 2010, 9, 263-285, 10.2174/187152810793358741
19. Adewole, S. O.; Caxton-Martins, E. A.; Ojewole, J. A. Protective effect of quercetin on the morphology of pancreatic beta-cells of streptozotocin-treated diabetic rats. Afr. J. Tradit., Complementary Altern. Med. 2006, 4, 64-74
20. Kim, J. H.; Kang, M. J.; Choi, H. N.; Jeong, S. M.; Lee, Y. M.; Kim, J. I. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutr. Res. Pract. 2011, 5, 107-111, 10.4162/nrp.2011.5.2.107
21. Shi, G. J.; Li, Y.; Cao, Q. H.; Wu, H. X.; Tang, X. Y.; Gao, X. H.; Yu, J. Q.; Chen, Z.; Yang, Y. In vitro and in vivo evidence that quercetin protects against diabetes and its complications: A systematic review of the literature. Biomed. Pharmacother. 2019, 109, 1085-1099, 10.1016/j.biopha.2018.10.130
22. Youl, E.; Bardy, G.; Magous, R.; Cros, G.; Sejalon, F.; Virsolvy, A.; Richard, S.; Quignard, J. F.; Gross, R.; Petit, P.; Bataille, D.; Oiry, C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic beta-cells against oxidative damage via the ERK1/2 pathway. Br. J. Pharmacol. 2010, 161, 799-814, 10.1111/j.1476-5381.2010.00910.x
23. Yang, D. K.; Kang, H. S. Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats. Biomol. Ther. 2018, 26, 130-138, 10.4062/biomolther.2017.254
24. Vessal, M.; Hemmati, M.; Vasei, M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol. 2003, 135, 357-364, 10.1016/S1532-0456(03)00140-6
25. Alam, M. M.; Meerza, D.; Naseem, I. Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci. 2014, 109, 8-14, 10.1016/j.lfs.2014.06.005
26. Mahesh, T.; Menon, V. P. Quercetin allievates oxidative stress in streptozotocin-induced diabetic rats. Phytother. Res. 2004, 18, 123-127, 10.1002/ptr.1374
27. Srinivasan, P.; Vijayakumar, S.; Kothandaraman, S.; Palani, M. Anti-diabetic activity of quercetin extracted from Phyllanthus emblica L. fruit: In silico and in vivo approaches. J. Pharm. Anal. 2018, 8, 109-118, 10.1016/j.jpha.2017.10.005
28. Sharma, G.; Kumar, S.; Sharma, M.; Upadhyay, N.; Kumar, S.; Ahmed, Z.; Mahindroo, N. Anti-Diabetic, Anti-oxidant and anti-adipogenic potential of quercetin rich ethyl acetate fraction of Prunus persica. Pharmacogn. J. 2018, 10, 463-469, 10.5530/pj.2018.3.76
29. Gaballah, H. H.; Zakaria, S. S.; Mwafy, S. E.; Tahoon, N. M.; Ebeid, A. M. Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats. Biomed. Pharmacother. 2017, 92, 331-339, 10.1016/j.biopha.2017.05.086
30. Jeong, S. M.; Kang, M. J.; Choi, H. N.; Kim, J. H.; Kim, J. I. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr. Res. Pract. 2012, 6, 201-207, 10.4162/nrp.2012.6.3.201
31. Hamilton, K. E.; Rekman, J. F.; Gunnink, L. K.; Busscher, B. M.; Scott, J. L.; Tidball, A. M.; Stehouwer, N. R.; Johnecheck, G. N.; Looyenga, B. D.; Louters, L. L. Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1. Biochimie 2018, 151, 107-114, 10.1016/j.biochi.2018.05.012
32. Dai, X.; Ding, Y.; Zhang, Z.; Cai, X.; Bao, L.; Li, Y. Quercetin but not quercitrin ameliorates tumor necrosis factor-alpha-induced insulin resistance in C2C12 skeletal muscle cells. Biol. Pharm. Bull. 2013, 36, 788-795, 10.1248/bpb.b12-00947
33. Henagan, T. M.; Cefalu, W. T.; Ribnicky, D. M.; Noland, R. C.; Dunville, K.; Campbell, W. W.; Stewart, L. K.; Forney, L. A.; Gettys, T. W.; Chang, J. S.; Morrison, C. D. In vivo effects of dietary quercetin and quercetin-rich red onion extract on skeletal muscle mitochondria, metabolism, and insulin sensitivity. Genes Nutr. 2015, 10, 451, 10.1007/s12263-014-0451-1
34. Dias, A. S.; Porawski, M.; Alonso, M.; Marroni, N.; Collado, P. S.; Gonzalez-Gallego, J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. The. J. Nutr. 2005, 135, 2299-2304, 10.1093/jn/135.10.2299
35. Sirovina, D.; Orsolic, N.; Koncic, M. Z.; Kovacevic, G.; Benkovic, V.; Gregorovic, G. Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Hum. Exp. Toxicol. 2013, 32, 1058-1066, 10.1177/0960327112472993
36. Khaki, A.; Nouri, M.; Fathiazad, F.; Ahmadi-Ashtiani, H.; Rastgar, H.; Rezazadeh, S. Protective Effects of Quercetin on Spermatogenesis in Streptozotocin-induced Diabetic Rat. J. Med. Plants 2009, 1, 57-64
37. Khaki, A. A. Evaluation Effects of Quercetin on Liver Apoptosis in Streptozotocin-induced Diabetic Rat. J. Med. Plants 2009, 1, 70-78
38. Jahan, S.; Iftikhar, N.; Ullah, H.; Rukh, G.; Hussain, I. Alleviative effect of quercetin on rat testis against arsenic: a histological and biochemical study. Syst. Biol. Reprod. Med. 2015, 61, 89-95, 10.3109/19396368.2014.998350
39. Kanter, M.; Aktas, C.; Erboga, M. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis. Food Chem. Toxicol. 2012, 50, 719-725, 10.1016/j.fct.2011.11.051
40. Nuckols, T. K.; Keeler, E.; Anderson, L. J.; Green, J.; Morton, S. C.; Doyle, B. J.; Shetty, K.; Arifkhanova, A.; Booth, M.; Shanman, R.; Shekelle, P. Economic Evaluation of Quality Improvement Interventions Designed to Improve Glycemic Control in Diabetes: A Systematic Review and Weighted Regression Analysis. Diabetes care 2018, 41, 985-993, 10.2337/dc17-1495
41. Sundstrom, J. M.; Hernandez, C.; Weber, S. R.; Zhao, Y.; Dunklebarger, M.; Tiberti, N.; Laremore, T.; Simo-Servat, O.; Garcia-Ramirez, M.; Barber, A. J.; Gardner, T. W.; Simo, R. Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases. Invest Ophthalmol. Visual Sci. 2018, 59, 2264-2274, 10.1167/iovs.17-23678
42. Li, X. H.; Xin, X.; Wang, Y.; Wu, J. Z.; Jin, Z. D.; Ma, L. N.; Nie, C. J.; Xiao, X.; Hu, Y.; Jin, M. W. Pentamethylquercetin protects against diabetes-related cognitive deficits in diabetic Goto-Kakizaki rats. J. Alzheimer's Dis. 2013, 34, 755-767, 10.3233/JAD-122017
43. Chen, B.; He, T.; Xing, Y.; Cao, T. Effects of quercetin on the expression of MCP-1, MMP-9 and VEGF in rats with diabetic retinopathy. Exp. Ther. Med. 2017, 14, 6022-6026, 10.3892/etm.2017.5275
44. Porcu, E. P.; Cossu, M.; Rassu, G.; Giunchedi, P.; Cerri, G.; Pourova, J.; Najmanova, I.; Migkos, T.; Pilarova, V.; Novakova, L.; Mladenka, P.; Gavini, E. Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects. Int. J. Pharm. 2018, 541, 224-233, 10.1016/j.ijpharm.2018.02.036
45. Häckl, L. P. N.; Cuttle, G.; Dovichi, S. S.; Lima-Landman, M. T.; Nicolau, M. Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I. Pharmacology 2002, 65, 182-186, 10.1159/000064341
46. Linz, W.; Wiemer, G.; Gohlke, P.; Unger, T.; Scholkens, B. A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev. 1995, 47, 25-49
47. Jalili, T.; Takeishi, Y.; Song, G.; Ball, N. A.; Howles, G.; Walsh, R. A. PKC translocation without changes in Galphaq and PLC-beta protein abundance in cardiac hypertrophy and failure. J. Am. Phys. 1999, 277, H2298-H2304, 10.1152/ajpheart.1999.277.6.H2298
48. Collins, J. F.; Pawloski-Dahm, C.; Davis, M. G.; Ball, N.; Dorn, G. W., 2nd; Walsh, R. A. The role of the cytoskeleton in left ventricular pressure overload hypertrophy and failure. J. Mol. Cell. Cardiol. 1996, 28, 1435-1443, 10.1006/jmcc.1996.0134
49. Sánchez, M.; Galisteo, M.; Vera, R.; Villar, I. C.; Zarzuelo, A.; Tamargo, J.; Perez-Vizcaino, F.; Duarte, J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J. Hypertens. 2006, 24, 75-84, 10.1097/01.hjh.0000198029.22472.d9
50. Machha, A.; Achike, F. I.; Mustafa, A. M.; Mustafa, M. R. Quercetin, a flavonoid antioxidant, modulates endothelium-derived nitric oxide bioavailability in diabetic rat aortas. Nitric Oxide 2007, 16, 442-447, 10.1016/j.niox.2007.04.001
51. Mezesova, L.; Bartekova, M.; Javorkova, V.; Vlkovicova, J.; Breier, A.; Vrbjar, N. Effect of quercetin on kinetic properties of renal Na,K-ATPase in normotensive and hypertensive rats. J. Physiol. Pharmacol. 2010, 61, 593-598
52. Prince, P. S.; Sathya, B. Pretreatment with quercetin ameliorates lipids, lipoproteins and marker enzymes of lipid metabolism in isoproterenol treated cardiotoxic male Wistar rats. Eur. J. Pharmacol. 2010, 635, 142-148, 10.1016/j.ejphar.2010.02.019
53. Rezabakhsh, A.; Rahbarghazi, R.; Malekinejad, H.; Fathi, F.; Montaseri, A.; Garjani, A. Quercetin alleviates high glucose-induced damage on human umbilical vein endothelial cells by promoting autophagy. Phytomedicine 2019, 56, 183-193, 10.1016/j.phymed.2018.11.008
54. He, Y.; Cao, X.; Guo, P.; Li, X.; Shang, H.; Liu, J.; Xie, M.; Xu, Y.; Liu, X. Quercetin induces autophagy via FOXO1-dependent pathways and autophagy suppression enhances quercetin-induced apoptosis in PASMCs in hypoxia. Free Radical Biol. Med. 2017, 103, 165-176, 10.1016/j.freeradbiomed.2016.12.016
55. Li, Y.; Chen, M.; Wang, J.; Guo, X.; Xiao, L.; Liu, P.; Liu, L.; Tang, Y.; Yao, P. Quercetin ameliorates autophagy in alcohol liver disease associated with lysosome through mTOR-TFEB pathway. J. Funct. Foods 2019, 52, 177-185, 10.1016/j.jff.2018.10.033
56. Godoy, J. A.; Lindsay, C. B.; Quintanilla, R. A.; Carvajal, F. J.; Cerpa, W.; Inestrosa, N. C. Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Abeta Aggregates in Hippocampal Neurons: the Role of Mitochondria. Mol. Neurobiol. 2017, 54, 7116-7128, 10.1007/s12035-016-0203-x
57. Chen, L. C.; Chen, Y. C.; Su, C. Y.; Hong, C. S.; Ho, H. O.; Sheu, M. T. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. Int. J. Nanomed. 2016, 11, 1557-1566, 10.2147/IJN.S103681
58. Moreno, L.; Puerta, E.; Suarez-Santiago, J. E.; Santos-Magalhaes, N. S.; Ramirez, M. J.; Irache, J. M. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer's disease. Int. J. Pharm. 2017, 517, 50-57, 10.1016/j.ijpharm.2016.11.061
59. Palle, S.; Neerati, P. Quercetin nanoparticles attenuates scopolamine induced spatial memory deficits and pathological damages in rats. Bull. Fac. Pharm. 2017, 55, 101-106, 10.1016/j.bfopcu.2016.10.004
60. Sharma, D. R.; Wani, W. Y.; Sunkaria, A.; Kandimalla, R. J.; Sharma, R. K.; Verma, D.; Bal, A.; Gill, K. D. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus. Neuroscience 2016, 324, 163-176, 10.1016/j.neuroscience.2016.02.055
61. Sabogal-Guáqueta, A. M.; Munoz-Manco, J. I.; Ramirez-Pineda, J. R.; Lamprea-Rodriguez, M.; Osorio, E.; Cardona-Gomez, G. P. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice. Neuropharmacology 2015, 93, 134-145, 10.1016/j.neuropharm.2015.01.027
62. Zhang, X.; Hu, J.; Zhong, L.; Wang, N.; Yang, L.; Liu, C. C.; Li, H.; Wang, X.; Zhou, Y.; Zhang, Y.; Xu, H.; Bu, G.; Zhuang, J. Quercetin stabilizes apolipoprotein E and reduces brain Abeta levels in amyloid model mice. Neuropharmacology 2016, 108, 179-192, 10.1016/j.neuropharm.2016.04.032
63. JUNG, S. H.; Murphy, E. A.; McClellan, J. L.; Carmichael, M. D.; Davis, J. M. The dietary flavonoid quercetin decreases neuroinflammation in a mouse model of Alzheimer's disease. FASEB J. 2010, 24, 604-617
64. Dong, Y. S.; Wang, J. L.; Feng, D. Y.; Qin, H. Z.; Wen, H.; Yin, Z. M.; Gao, G. D.; Li, C. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int. J. Med. Sci. 2014, 11, 282-290, 10.7150/ijms.7634
65. Ansari, M. A.; Abdul, H. M.; Joshi, G.; Opii, W. O.; Butterfield, D. A. Protective effect of quercetin in primary neurons against Abeta(1-42): relevance to Alzheimer's disease. J. Nutr. Biochem. 2009, 20, 269-275, 10.1016/j.jnutbio.2008.03.002
66. Heo, H. J.; Lee, C. Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J. Agric. Food Chem. 2004, 52, 7514-7517, 10.1021/jf049243r
67. Braidy, N.; Behzad, S.; Habtemariam, S.; Ahmed, T.; Daglia, M.; Nabavi, S. M.; Sobarzo-Sanchez, E.; Nabavi, S. F. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease. CNS Neurol. Disord.: Drug Targets 2017, 16, 387-397, 10.2174/1871527316666170328113309
68. Kant, V.; Jangir, B. L.; Nigam, A.; Kumar, V.; Sharma, S. Dose regulated cutaneous wound healing potential of quercetin in male rats. Wound Med. 2017, 19, 82-87, 10.1016/j.wndm.2017.10.004
69. Borghi, S. M.; Mizokami, S. S.; Pinho-Ribeiro, F. A.; Fattori, V.; Crespigio, J.; Clemente-Napimoga, J. T.; Napimoga, M. H.; Pitol, D. L.; Issa, J. P. M.; Fukada, S. Y.; Casagrande, R.; Verri, W. A., Jr. The flavonoid quercetin inhibits titanium dioxide (TiO2)-induced chronic arthritis in mice. J. Nutr. Biochem. 2018, 53, 81-95, 10.1016/j.jnutbio.2017.10.010
70. Haleagrahara, N.; Miranda-Hernandez, S.; Alim, M. A.; Hayes, L.; Bird, G.; Ketheesan, N. Therapeutic effect of quercetin in collagen-induced arthritis. Biomed. Pharmacother. 2017, 90, 38-46, 10.1016/j.biopha.2017.03.026
71. Li, G.; Shen, X.; Wei, Y.; Si, X.; Deng, X.; Wang, J. Quercetin reduces Streptococcus suis virulence by inhibiting suilysin activity and inflammation. Int. Immunopharmacol. 2019, 69, 71-78, 10.1016/j.intimp.2019.01.017
72. Bustos, P. S.; Deza-Ponzio, R.; Paez, P. L.; Albesa, I.; Cabrera, J. L.; Virgolini, M. B.; Ortega, M. G. Protective effect of quercetin in gentamicin-induced oxidative stress in vitro and in vivo in blood cells. Effect on gentamicin antimicrobial activity. Environ. Toxicol. Pharmacol. 2016, 48, 253-264, 10.1016/j.etap.2016.11.004
73. Zeng, H.; Guo, X.; Zhou, F.; Xiao, L.; Liu, J.; Jiang, C.; Xing, M.; Yao, P. Quercetin alleviates ethanol-induced liver steatosis associated with improvement of lipophagy. Food Chem. Toxicol. 2019, 125, 21-28, 10.1016/j.fct.2018.12.028
74. Akinmoladun, A. C.; Oladejo, C. O.; Josiah, S. S.; Famusiwa, C. D.; Ojo, O. B.; Olaleye, M. T. Catechin, quercetin and taxifolin improve redox and biochemical imbalances in rotenone-induced hepatocellular dysfunction: Relevance for therapy in pesticide-induced liver toxicity?. Pathophysiology 2018, 25, 365-371, 10.1016/j.pathophys.2018.07.002
75. Adeoye, A. O.; Ojowu, J.; Daniel, O. O.; Olorunsogo, O. O. Inhibition of liver mitochondrial membrane permeability transition pore opening by quercetin and vitamin E in streptozotocin-induced diabetic rats. Biochem. Biophys. Res. Commun. 2018, 504, 460-469, 10.1016/j.bbrc.2018.08.114
76. Lee, K. S.; Park, S. N. Cytoprotective effects and mechanisms of quercetin, quercitrin and avicularin isolated from Lespedeza cuneata G. Don against ROS-induced cellular damage. J. Ind. Eng. Chem. 2019, 71, 160-166, 10.1016/j.jiec.2018.11.018
77. Nile, S. H.; Nile, A. S.; Keum, Y. S.; Sharma, K. Utilization of quercetin and quercetin glycosides from onion (Allium cepa L.) solid waste as an antioxidant, urease and xanthine oxidase inhibitors. Food Chem. 2017, 235, 119-126, 10.1016/j.foodchem.2017.05.043
78. Rastogi, S.; Haldar, C. Comparative effect of melatonin and quercetin in counteracting LPS induced oxidative stress in bone marrow mononuclear cells and spleen of Funambulus pennanti. Food Chem. Toxicol. 2018, 120, 243-252, 10.1016/j.fct.2018.06.062
79. Lesjak, M.; Beara, I.; Simin, N.; Pintać, D.; Majkić, T.; Bekvalac, K.; Orčić, D.; Mimica-Dukić, N. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods 2018, 40, 68-75, 10.1016/j.jff.2017.10.047
80. Luangaram, S.; Kukongviriyapan, U.; Pakdeechote, P.; Kukongviriyapan, V.; Pannangpetch, P. Protective effects of quercetin against phenylhydrazine-induced vascular dysfunction and oxidative stress in rats. Food Chem. Toxicol. 2007, 45, 448-455, 10.1016/j.fct.2006.09.008
81. Moreira, L.; Araujo, I.; Costa, T.; Correia-Branco, A.; Faria, A.; Martel, F.; Keating, E. Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism. Exp. Cell Res. 2013, 319, 1784-1795, 10.1016/j.yexcr.2013.05.001
82. Dhanya, R.; Arya, A. D.; Nisha, P.; Jayamurthy, P. Quercetin, a Lead Compound against Type 2 Diabetes Ameliorates Glucose Uptake via AMPK Pathway in Skeletal Muscle Cell Line. Front. Pharmacol. 2017, 8, 336, 10.3389/fphar.2017.00336
83. Choi, H.-N.; Jeong, S.-M.; Huh, G. H.; Kim, J.-I. Quercetin ameliorates insulin sensitivity and liver steatosis partly by increasing adiponectin expression in ob/ob mice. Food Sci. Biotechnol. 2015, 24, 273-279, 10.1007/s10068-015-0036-9
84. Babacanoglu, C.; Yildirim, N.; Sadi, G.; Pektas, M. B.; Akar, F. Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem. Toxicol. 2013, 60, 160-167, 10.1016/j.fct.2013.07.026
85. Dey, A.; Kumar, S. M. Cytochrome P450 2E1 and hyperglycemia-induced liver injury. Cell Biol. Toxicol. 2011, 27, 285-310, 10.1007/s10565-011-9188-4
86. Maksymchuk, O.; Shysh, A.; Rosohatska, I.; Chashchyn, M. Quercetin prevents type 1 diabetic liver damage through inhibition of CYP2E1. Pharmacol. Rep. 2017, 69, 1386-1392, 10.1016/j.pharep.2017.05.020
87. Xu, X.; Chen, P.; Zheng, Q.; Wang, Y.; Chen, W. Effect of pioglitazone on diabetic nephropathy and expression of HIF-1alpha and VEGF in the renal tissues of type 2 diabetic rats. Diabetes Res. Clin. Pract. 2011, 93, 63-69, 10.1016/j.diabres.2011.03.019
88. Chen, P.; Chen, J.; Zheng, Q.; Chen, W.; Wang, Y.; Xu, X. Pioglitazone, extract of compound Danshen dripping pill, and quercetin ameliorate diabetic nephropathy in diabetic rats. J. Endocrinol. Invest. 2013, 36, 422-427, 10.3275/8763
89. Roth, G.; Kotzka, J.; Kremer, L.; Lehr, S.; Lohaus, C.; Meyer, H. E.; Krone, W.; Muller-Wieland, D. MAP kinases Erk1/2 phosphorylate sterol regulatory element-binding protein (SREBP)-1a at serine 117 in vitro. The. J. Biol. Chem. 2000, 275, 33302-33307, 10.1074/jbc.M005425200
90. Elbe, H.; Vardi, N.; Esrefoglu, M.; Ates, B.; Yologlu, S.; Taskapan, C. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats. Hum. Exp. Toxicol. 2015, 34, 100-113, 10.1177/0960327114531995
91. Thomas, A. A.; Feng, B.; Chakrabarti, S. ANRIL: A Regulator of VEGF in Diabetic Retinopathy. Invest Ophthalmol. Visual Sci. 2017, 58, 470-480, 10.1167/iovs.16-20569
92. Kumar, B.; Gupta, S. K.; Srinivasan, B. P.; Nag, T. C.; Srivastava, S.; Saxena, R.; Jha, K. A. Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc. Res. 2013, 87, 65-74, 10.1016/j.mvr.2013.01.002
93. Ibarra, J.; Bland, M.; Gonzalez, M.; Garcia, C. Quercetin ameliorates hyperglycemia-induced inflammation and apoptosis in the retina and lateral geniculate nucleus in a rat model of type 2 diabetes mellitus (688.8). FASEB J. 2014, 28, 688-8
94. Greindling, K. K.; Lassegue, B.; Alexander, R. W. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 1996, 36, 281-306, 10.1146/annurev.pa.36.040196.001433
95. Suri, S.; Liu, X. H.; Rayment, S.; Hughes, D. A.; Kroon, P. A.; Needs, P. W.; Taylor, M. A.; Tribolo, S.; Wilson, V. G. Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery. Br. J. Pharmacol. 2010, 159, 566-575, 10.1111/j.1476-5381.2009.00556.x
96. Ganz, P.; Vita, J. A. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003, 108, 2049-2053, 10.1161/01.CIR.0000089507.19675.F9
97. Wan, L. L.; Xia, J.; Ye, D.; Liu, J.; Chen, J.; Wang, G. Effects of quercetin on gene and protein expression of NOX and NOS after myocardial ischemia and reperfusion in rabbit. Cardiovasc. Ther. 2009, 27, 28-33, 10.1111/j.1755-5922.2009.00071.x
98. Ahmed, L. A.; Salem, H. A.; Attia, A. S.; El-Sayed, M. E. Enhancement of amlodipine cardioprotection by quercetin in ischaemia/reperfusion injury in rats. J. Pharm. Pharmacol. 2009, 61, 1233-1241, 10.1211/jpp.61.09.0014
99. Kleemann, R.; Verschuren, L.; Morrison, M.; Zadelaar, S.; van Erk, M. J.; Wielinga, P. Y.; Kooistra, T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011, 218, 44-52, 10.1016/j.atherosclerosis.2011.04.023
100. Yan, L.; Zhang, J. D.; Wang, B.; Lv, Y. J.; Jiang, H.; Liu, G. L.; Qiao, Y.; Ren, M.; Guo, X. F. Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-gamma expression and suppressing AP-1 activity. PLoS One 2013, 8, e72548 10.1371/journal.pone.0072548
101. Satoh, H.; Nishida, S. Cardio-electopharmacology and vasodilating mechanisms of quercetin. Med. Chem. 2014, 4, 523-530, 10.4172/2161-0444.1000189
102. Wang, Y.; Zhang, Z. Z.; Wu, Y.; Ke, J. J.; He, X. H.; Wang, Y. L. Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2013, 46, 861-867, 10.1590/1414-431X20133036
103. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; Rissanen, H.; Heliovaara, M.; Reunanen, A.; Hakulinen, T.; Aromaa, A. Flavonoid intake and risk of chronic diseases. The American journal of clinical nutrition 2002, 76, 560-568, 10.1093/ajcn/76.3.560
104. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kurbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A. E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; Wolffram, S.; Muller, M. J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102, 1065-1074, 10.1017/S0007114509359127
105. Chekalina, N.; Burmak, Y.; Petrov, Y.; Borisova, Z.; Manusha, Y.; Kazakov, Y.; Kaidashev, I. Quercetin reduces the transcriptional activity of NF-kB in stable coronary artery disease. Indian Heart J. 2018, 70, 593-597, 10.1016/j.ihj.2018.04.006
106. Zahedi, M.; Ghiasvand, R.; Feizi, A.; Asgari, G.; Darvish, L. Does Quercetin Improve Cardiovascular Risk factors and Inflammatory Biomarkers in Women with Type 2 Diabetes: A Double-blind Randomized Controlled Clinical Trial. Int. J. Prev. Med. 2013, 4, 777-785
107. Nakayama, H.; Tsuge, N.; Sawada, H.; Higashi, Y. Chronic intake of onion extract containing quercetin improved postprandial endothelial dysfunction in healthy men. Journal of the American College of Nutrition 2013, 32, 160-164, 10.1080/07315724.2013.797858
108. Xie, M.; Morales, C. R.; Lavandero, S.; Hill, J. A. Tuning flux: autophagy as a target of heart disease therapy. Curr. Opin. Cardiol. 2011, 26, 216-222, 10.1097/HCO.0b013e328345980a
109. Sasaki, Y.; Ikeda, Y.; Iwabayashi, M.; Akasaki, Y.; Ohishi, M. The Impact of Autophagy on Cardiovascular Senescence and Diseases. Int Heart J 2017, 58, 666-673, 10.1536/ihj.17-246
110. Suganthy, N.; Devi, K. P.; Nabavi, S. F.; Braidy, N.; Nabavi, S. M. Bioactive effects of quercetin in the central nervous system: Focusing on the mechanisms of actions. Biomed. Pharmacother. 2016, 84, 892-908, 10.1016/j.biopha.2016.10.011
111. Jiménez-Aliaga, K.; Bermejo-Bescos, P.; Benedi, J.; Martin-Aragon, S. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sci. 2011, 89, 939-945, 10.1016/j.lfs.2011.09.023
112. McGeer, P. L.; McGeer, E. G. The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol. 2013, 126, 479-497, 10.1007/s00401-013-1177-7
113. Anand, R.; Gill, K. D.; Mahdi, A. A. Therapeutics of Alzheimer's disease: Past, present and future. Neuropharmacology 2014, 76, 27-50, 10.1016/j.neuropharm.2013.07.004
114. Maciel, R. M.; Carvalho, F. B.; Olabiyi, A. A.; Schmatz, R.; Gutierres, J. M.; Stefanello, N.; Zanini, D.; Rosa, M. M.; Andrade, C. M.; Rubin, M. A.; Schetinger, M. R.; Morsch, V. M.; Danesi, C. C.; Lopes, S. T. A. Neuroprotective effects of quercetin on memory and anxiogenic-like behavior in diabetic rats: Role of ectonucleotidases and acetylcholinesterase activities. Biomed. Pharmacother. 2016, 84, 559-568, 10.1016/j.biopha.2016.09.069
115. Richetti, S. K.; Blank, M.; Capiotti, K. M.; Piato, A. L.; Bogo, M. R.; Vianna, M. R.; Bonan, C. D. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav. Brain Res. 2011, 217, 10-15, 10.1016/j.bbr.2010.09.027
116. Islam, M. R.; Zaman, A.; Jahan, I.; Chakravorty, R.; Chakraborty, S. In silico QSAR analysis of quercetin reveals its potential as therapeutic drug for Alzheimer's disease. J. Young Pharm. 2013, 5, 173-179, 10.1016/j.jyp.2013.11.005
117. Ochiai, A.; Tanaka, S.; Imai, Y.; Yoshida, H.; Kanaoka, T.; Tanaka, T.; Taniguchi, M. New tyrosinase inhibitory decapeptide: Molecular insights into the role of tyrosine residues. J. Biosci. Bioeng. 2016, 121, 607-613, 10.1016/j.jbiosc.2015.10.010
118. Hridya, H.; Amrita, A.; Mohan, S.; Gopalakrishnan, M.; Dakshinamurthy, T. K.; Doss, G. P.; Siva, R. Functionality study of santalin as tyrosinase inhibitor: A potential depigmentation agent. Int. J. Biol. Macromol. 2016, 86, 383-389, 10.1016/j.ijbiomac.2016.01.098
119. Hu, Y. H.; Zhuang, J. X.; Yu, F.; Cui, Y.; Yu, W. W.; Yan, C. L.; Chen, Q. X. Inhibitory effects of cefotaxime on the activity of mushroom tyrosinase. J. Biosci. Bioeng. 2016, 121, 385-389, 10.1016/j.jbiosc.2015.08.005
120. Oyama, T.; Takahashi, S.; Yoshimori, A.; Yamamoto, T.; Sato, A.; Kamiya, T.; Abe, H.; Abe, T.; Tanuma, S. I. Discovery of a new type of scaffold for the creation of novel tyrosinase inhibitors. Bioorg. Med. Chem. 2016, 24, 4509-4515, 10.1016/j.bmc.2016.07.060
121. Fan, M.; Zhang, G.; Hu, X.; Xu, X.; Gong, D. Quercetin as a tyrosinase inhibitor: Inhibitory activity, conformational change and mechanism. Food Res. Int. 2017, 100, 226-233, 10.1016/j.foodres.2017.07.010
122. Athanasiou, K. A.; Darling, E. M.; Hu, J. C.; DuRaine, G. D.; Reddi, A. H. Articular Cartilage; CRC Press, 2017.
123. Laev, S. S.; Salakhutdinov, N. F. Anti-arthritic agents: Progress and potential. Bioorg. Med. Chem. 2015, 23, 3059-3080, 10.1016/j.bmc.2015.05.010
124. Cobelli, N.; Scharf, B.; Crisi, G. M.; Hardin, J.; Santambrogio, L. Mediators of the inflammatory response to joint replacement devices. Nat. Rev. Rheumatol. 2011, 7, 600-608, 10.1038/nrrheum.2011.128
125. Xu, J. G.; Jing, H. Q.; Ye, C. Y. Highly virulent Streptococcus suis infection and problems involved in the disease prevention and control in China. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26, 629-632
126. Gao, Z. Y.; Zhuang, H. Human infection due to Streptococcus suis. Zhonghua Liu Xing Bing Xue Za Zhi 2005, 26, 645-648
127. Huang, Y. T.; Teng, L. J.; Ho, S. W.; Hsueh, P. R. Streptococcus suis infection. J. Microbiol. Immunol. Infect. 2005, 38, 306-313
128. Abdel-Misih, S. R. Z.; Bloomston, M. Liver Anatomy. Surg. Clin. North Am. 2010, 90, 643-653, 10.1016/j.suc.2010.04.017
129. Asrani, S. K.; Devarbhavi, H.; Eaton, J.; Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 2019, 70, 151-171, 10.1016/j.jhep.2018.09.014
130. Sanders, L. H.; Timothy Greenamyre, J. Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radical Biol. Med. 2013, 62, 111-120, 10.1016/j.freeradbiomed.2013.01.003
131. Wu, T.-C.; Chan, S.-T.; Chang, C.-N.; Yu, P.-S.; Chuang, C.-H.; Yeh, S.-L. Quercetin and chrysin inhibit nickel-induced invasion and migration by downregulation of TLR4/NF-κB signaling in A549 cells. Chem.-Biol. Interact. 2018, 292, 101-109, 10.1016/j.cbi.2018.07.010
132. Teekaraman, D.; Elayapillai, S. P.; Viswanathan, M. P.; Jagadeesan, A. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line. Chem.-Biol. Interact. 2019, 300, 91-100, 10.1016/j.cbi.2019.01.008
133. Zhao, J.; Fang, Z.; Zha, Z.; Sun, Q.; Wang, H.; Sun, M.; Qiao, B. Quercetin inhibits cell viability, migration and invasion by regulating miR-16/HOXA10 axis in oral cancer. Eur. J. Pharmacol. 2019, 847, 11-18, 10.1016/j.ejphar.2019.01.006
134. Huang, D.-Y.; Dai, Z.-R.; Li, W.-M.; Wang, R.-G.; Yang, S.-M. Inhibition of EGF expression and NF-κB activity by treatment with quercetin leads to suppression of angiogenesis in nasopharyngeal carcinoma. Saudi J. Biol. Sci. 2018, 25, 826-831, 10.1016/j.sjbs.2016.11.011
135. Wang, C.; Qu, Z.; Kong, L.; Xu, L.; Zhang, M.; Liu, J.; Yang, Z. Quercetin ameliorates lipopolysaccharide-caused inflammatory damage via down-regulation of miR-221 in WI-38 cells. Exp. Mol. Pathol. 2019, 108, 1-8, 10.1016/j.yexmp.2019.03.002
136. Li, X.; Zhou, N.; Wang, J.; Liu, Z.; Wang, X.; Zhang, Q.; Liu, Q.; Gao, L.; Wang, R. Quercetin suppresses breast cancer stem cells (CD44+/CD24-) by inhibiting the PI3K/Akt/mTOR-signaling pathway. Life Sci. 2018, 196, 56-62, 10.1016/j.lfs.2018.01.014
137. Jia, L.; Huang, S.; Yin, X.; Zan, Y.; Guo, Y.; Han, L. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 2018, 208, 123-130, 10.1016/j.lfs.2018.07.027
138. Araújo, K. C. F.; de MB Costa, E. M.; Pazini, F.; Valadares, M. C.; de Oliveira, V. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products. Food Chem. Toxicol. 2013, 51, 93-96, 10.1016/j.fct.2012.09.015
139. Sánchez-González, P. D.; López-Hernández, F. J.; Dueñas, M.; Prieto, M.; Sánchez-López, E.; Thomale, J.; Ruiz-Ortega, M.; López-Novoa, J. M.; Morales, A. I. Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues. Food Chem. Toxicol. 2017, 107, 226-236, 10.1016/j.fct.2017.06.047
140. Erdogan, S.; Turkekul, K.; Dibirdik, I.; Doganlar, O.; Doganlar, Z. B.; Bilir, A.; Oktem, G. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway. Biomed. Pharmacother. 2018, 107, 793-805, 10.1016/j.biopha.2018.08.061
141. Li, S.; Pei, Y.; Wang, W.; Liu, F.; Zheng, K.; Zhang, X. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1. Biomed. Pharmacother. 2019, 114, 108839 10.1016/j.biopha.2019.108839
142. Chen, K.-C.; Hsu, W.-H.; Ho, J.-Y.; Lin, C.-W.; Chu, C.-Y.; Kandaswami, C. C.; Lee, M.-T.; Cheng, C.-H. Flavonoids Luteolin and Quercetin Inhibit RPS19 and contributes to metastasis of cancer cells through c-Myc reduction. J. Food Drug Anal. 2018, 26, 1180-1191, 10.1016/j.jfda.2018.01.012
143. Srivastava, N. S.; Srivastava, R. A. K. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer cells and modulate Wnt/β-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 2019, 52, 117-128, 10.1016/j.phymed.2018.09.224
144. Elmadany, N.; Khalil, E.; Vaccari, L.; Birarda, G.; Yousef, I.; Abu-Dahab, R. Antiproliferative activity of the combination of doxorubicin/quercetin on MCF7 breast cancer cell line: A combined study using colorimetric assay and synchrotron infrared microspectroscopy. Infrared Phys. Technol. 2018, 95, 141-147, 10.1016/j.infrared.2018.10.014
145. Shan, B.-E.; Wang, M.-X.; Li, R.-q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/β-catenin signaling pathway. Cancer invest. 2009, 27, 604-612, 10.1080/07357900802337191
146. Kim, H.; Seo, E.-M.; Sharma, A. R.; Ganbold, B.; Park, J.; Sharma, G.; Kang, Y.-H.; Song, D.-K.; Lee, S.-S.; Nam, J.-S. Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cells. Int. J. Oncol. 2013, 43, 1319-1325, 10.3892/ijo.2013.2036
147. Jeong, J. H.; An, J. Y.; Kwon, Y. T.; Rhee, J. G.; Lee, Y. J. Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression. J. Cell. Biochem. 2009, 106, 73-82, 10.1002/jcb.21977
148. Maurya, A. K.; Vinayak, M. Modulation of PKC signaling and induction of apoptosis through suppression of reactive oxygen species and tumor necrosis factor receptor 1 (TNFR1): key role of quercetin in cancer prevention. Tumor Biol. 2015, 36, 8913-8924, 10.1007/s13277-015-3634-5
149. Mead, J.; McNair, N. Antiparasitic activity of flavonoids and isoflavones against Cryptosporidium parvum and Encephalitozoon intestinalis. FEMS Microbiol. Lett. 2006, 259, 153-157, 10.1111/j.1574-6968.2006.00263.x
150. Calzada, F.; Correa-Basurto, J.; Barbosa, E.; Mendez-Luna, D.; Yepez-Mulia, L. Antiprotozoal Constituents from Annona cherimola Miller, a Plant Used in Mexican Traditional Medicine for the Treatment of Diarrhea and Dysentery. Pharmacogn. Mag. 2017, 13, 148-152, 10.4103/0973-1296.203976
151. Fonseca-Silva, F.; Inacio, J. D.; Canto-Cavalheiro, M. M.; Almeida-Amaral, E. E. Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis. PLoS One 2011, 6, e14666 10.1371/journal.pone.0014666
152. Cataneo, A. H. D.; Tomiotto-Pellissier, F.; Miranda-Sapla, M. M.; Assolini, J. P.; Panis, C.; Kian, D.; Yamauchi, L. M.; Colado Simao, A. N.; Casagrande, R.; Pinge-Filho, P.; Costa, I. N.; Verri, W. A., Jr; Conchon-Costa, I.; Pavanelli, W. R. Quercetin promotes antipromastigote effect by increasing the ROS production and anti-amastigote by upregulating Nrf2/HO-1 expression, affecting iron availability. Biomed. Pharmacother. 2019, 113, 108745 10.1016/j.biopha.2019.108745
153. Jean-Moreno, V.; Rojas, R.; Goyeneche, D.; Coombs, G. H.; Walker, J. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays. Exp. Parasitol. 2006, 112, 21-30, 10.1016/j.exppara.2005.08.014
154. de Sousa, L. R.; Wu, H.; Nebo, L.; Fernandes, J. B.; da Silva, M. F.; Kiefer, W.; Schirmeister, T.; Vieira, P. C. Natural products as inhibitors of recombinant cathepsin L of Leishmania mexicana. Exp. Parasitol. 2015, 156, 42-48, 10.1016/j.exppara.2015.05.016
155. Cortázar, T. M.; Coombs, G. H.; Walker, J. Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine. Exp. Parasitol. 2007, 116, 475-482, 10.1016/j.exppara.2007.02.018
156. Ganesh, D.; Fuehrer, H. P.; Starzengruber, P.; Swoboda, P.; Khan, W. A.; Reismann, J. A.; Mueller, M. S.; Chiba, P.; Noedl, H. Antiplasmodial activity of flavonol quercetin and its analogues in Plasmodium falciparum: evidence from clinical isolates in Bangladesh and standardized parasite clones. Parasitol. Res. 2012, 110, 2289-2295, 10.1007/s00436-011-2763-z
157. Penna-Coutinho, J.; Aguiar, A. C.; Krettli, A. U. Commercial drugs containing flavonoids are active in mice with malaria and in vitro against chloroquine-resistant Plasmodium falciparum. Mem. Inst. Oswaldo Cruz 2018, 113, e180279 10.1590/0074-02760180279
158. Kerboeuf, D.; Riou, M.; Guegnard, F. Flavonoids and related compounds in parasitic disease control. Mini-Rev. Med. Chem. 2008, 8, 116-128, 10.2174/138955708783498168
159. Smith, P.; Ho, C. K.; Takagi, Y.; Djaballah, H.; Shuman, S. Nanomolar Inhibitors of Trypanosoma brucei RNA Triphosphatase. mBio 2016, 7, e00058 10.1128/mBio.00058-16
160. Dodson, H. C.; Lyda, T. A.; Chambers, J. W.; Morris, M. T.; Christensen, K. A.; Morris, J. C. Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1. Exp. Parasitol. 2011, 127, 423-428, 10.1016/j.exppara.2010.10.011
161. Worthen, C.; Jensen, B. C.; Parsons, M. Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei. PLoS Neglected Trop. Dis. 2010, 4, e678 10.1371/journal.pntd.0000678
162. Mamani-Matsuda, M.; Rambert, J.; Malvy, D.; Lejoly-Boisseau, H.; Daulouede, S.; Thiolat, D.; Coves, S.; Courtois, P.; Vincendeau, P.; Mossalayi, M. D. Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob. Agents Chemother. 2004, 48, 924-929, 10.1128/AAC.48.3.924-929.2004
163. Pérez-Cruz, F.; Serra, S.; Delogu, G.; Lapier, M.; Maya, J. D.; Olea-Azar, C.; Santana, L.; Uriarte, E. Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives. Bioorg. Med. Chem. Lett. 2012, 22, 5569-5573, 10.1016/j.bmcl.2012.07.013
164. Calzada, F.; Alanis, A. D. Additional antiprotozoal flavonol glycosides of the aerial parts of Helianthemum glomeratum. Phytother. Res. 2007, 21, 78-80, 10.1002/ptr.2031
165. El Souda, S. S.; Matloub, A. A.; Nepveuc, F.; Valentin, A.; Roques, C. Phenolic composition and prospective anti-infectious properties of Atriplex lindleyi. Asian Pac. J. Trop. Dis. 2015, 5, 786-791, 10.1016/S2222-1808(15)60931-8
166. Oliveira, F. Q.; Andrade-Neto, V.; Krettli, A. U.; Brandao, M. G. New evidences of antimalarial activity of Bidens pilosa roots extract correlated with polyacetylene and flavonoids. J. Ethnopharmacol. 2004, 93, 39-42, 10.1016/j.jep.2004.03.026
167. Montrieux, E.; Perera, W. H.; Garcia, M.; Maes, L.; Cos, P.; Monzote, L. In vitro and in vivo activity of major constituents from Pluchea carolinensis against Leishmania amazonensis. Parasitol. Res. 2014, 113, 2925-2932, 10.1007/s00436-014-3954-1
168. Muzitano, M. F.; Falcao, C. A.; Cruz, E. A.; Bergonzi, M. C.; Bilia, A. R.; Vincieri, F. F.; Rossi-Bergmann, B.; Costa, S. S. Oral metabolism and efficacy of Kalanchoe pinnata flavonoids in a murine model of cutaneous leishmaniasis. Planta Med. 2009, 75, 307-311, 10.1055/s-0028-1088382
169. Pereira, C. A. J.; Oliveira, L. L. S.; Coaglio, A. L.; Santos, F. S. O.; Cezar, R. S. M.; Mendes, T.; Oliveira, F. L. P.; Conzensa, G.; Lima, W. S. Anti-helminthic activity of Momordica charantia L. against Fasciola hepatica eggs after twelve days of incubation in vitro. Vet. Parasitol. 2016, 228, 160-166, 10.1016/j.vetpar.2016.08.025
170. Vila-Nova, N. S.; Morais, S. M.; Falcão, M. J. C.; Bevilaqua, C. M. L.; Rondon, F. C. M.; Wilson, M. E.; Vieira, I. G. P.; Andrade, H. F. Leishmanicidal and cholinesterase inhibiting activities of phenolic compounds of Dimorphandra gardneriana and Platymiscium floribundum, native plants from Caatinga biome. Pesq. Vet. Bras. 2012, 32, 1164-1168, 10.1590/S0100-736X2012001100015
171. Kheirandish, F.; Delfan, B.; Mahmoudvand, H.; Moradi, N.; Ezatpour, B.; Ebrahimzadeh, F.; Rashidipour, M. Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract. Biomed. Pharmacother. 2016, 82, 208-215, 10.1016/j.biopha.2016.04.040
172. Jansen, O.; Tchinda, A. T.; Loua, J.; Esters, V.; Cieckiewicz, E.; Ledoux, A.; Toukam, P. D.; Angenot, L.; Tits, M.; Balde, A. M.; Frederich, M. Antiplasmodial activity of Mezoneuron benthamianum leaves and identification of its active constituents. J. Ethnopharmacol. 2017, 203, 20-26, 10.1016/j.jep.2017.03.021
173. Calixto Júnior, J. T.; de Morais, S. M.; Gomez, C. V.; Molas, C. C.; Rolon, M.; Boligon, A. A.; Athayde, M. L.; de Morais Oliveira, C. D.; Tintino, S. R.; Henrique Douglas, M. C. Phenolic composition and antiparasitic activity of plants from the Brazilian Northeast "Cerrado". Saudi J. Biol. Sci. 2016, 23, 434-440, 10.1016/j.sjbs.2015.10.009
174. Cunha, N. L.; Uchoa, C. J.; Cintra, L. S.; de Souza, H. C.; Peixoto, J. A.; Silva, C. P.; Magalhaes, L. G.; Gimenez, V. M.; Groppo, M.; Rodrigues, V.; da Silva Filho, A. A.; Andrade, E. S. M. L.; Cunha, W. R.; Pauletti, P. M.; Januario, A. H. In vitro schistosomicidal activity of some brazilian cerrado species and their isolated compounds. J. Evidence-Based Complementary Altern. Med. 2012, 2012, 173614 10.1155/2012/173614
175. Iwu, M. M.; Obidoa, O.; Anazodo, M. Biochemical mechanism of the antimalarial activity of Azadirachta indica leaf extract. Pharmacol. Res. Commun. 1986, 18, 81-91, 10.1016/0031-6989(86)90161-X
176. Houël, E.; Nardella, F.; Jullian, V.; Valentin, A.; Vonthron-Senecheau, C.; Villa, P.; Obrecht, A.; Kaiser, M.; Bourreau, E.; Odonne, G.; Fleury, M.; Bourdy, G.; Eparvier, V.; Deharo, E.; Stien, D. Wayanin and guaijaverin, two active metabolites found in a Psidium acutangulum Mart. ex DC (syn. P. persoonii McVaugh) (Myrtaceae) antimalarial decoction from the Wayana Amerindians. J. Ethnopharmacol. 2016, 187, 241-248, 10.1016/j.jep.2016.04.053
177. de Souza, C. E. S.; da Silva, A. R. P.; Gomez, M. C. V.; Rolom, M.; Coronel, C.; da Costa, J. G. M.; Sousa, A. K.; Rolim, L. A.; de Souza, F. H. S.; Coutinho, H. D. M. Anti-Trypanosoma, anti-Leishmania and cytotoxic activities of natural products from Psidium brownianum Mart. ex DC. and Psidium guajava var. Pomifera analysed by LC-MS. Acta Trop. 2017, 176, 380-384, 10.1016/j.actatropica.2017.09.009
178. Méabed, E. M. H.; Abou-Sreea, A. I. B.; Roby, M. H. H. Chemical analysis and giardicidal effectiveness of the aqueous extract of Cymbopogon citratus Stapf. Parasitol. Res. 2018, 117, 1745-1755, 10.1007/s00436-018-5855-1
179. Das, B. B.; Sen, N.; Roy, A.; Dasgupta, S. B.; Ganguly, A.; Mohanta, B. C.; Dinda, B.; Majumder, H. K. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I. Nucleic Acids Res. 2006, 34, 1121-1132, 10.1093/nar/gkj502
180. Khalid, S. A.; Farouk, A.; Geary, T. G.; Jensen, J. B. Potential antimalarial candidates from African plants: and in vitro approach using Plasmodium falciparum. J. Ethnopharmacol. 1986, 15, 201-209, 10.1016/0378-8741(86)90156-X
181. Gibellini, L.; Pinti, M.; Nasi, M.; Montagna, J. P.; De Biasi, S.; Roat, E.; Bertoncelli, L.; Cooper, E. L.; Cossarizza, A. Quercetin and cancer chemoprevention. J. Evidence-Based Complementary Altern. Med. 2011, 2011, 591356 10.1093/ecam/neq053
182. Shafabakhsh, R.; Asemi, Z. Quercetin: a natural compound for ovarian cancer treatment. J. Ovarian Res. 2019, 12, 55 10.1186/s13048-019-0530-4
183. Alper, M.; Güneş, H. The anticancer and anti-inflammatory effects of Centaurea solstitialis extract on human cancer cell lines. Turk. J. Pharm. Sci. 2019, 16, 273-281, 10.4274/tjps.galenos.2018.27146
184. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer letters 2008, 269, 315-325, 10.1016/j.canlet.2008.03.046
185. Zhou, W.; Kallifatidis, G.; Baumann, B.; Rausch, V.; Mattern, J.; Gladkich, J.; Giese, N.; Moldenhauer, G.; Wirth, T.; Buchler, M. W.; Salnikov, A. V.; Herr, I. Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int. J. Oncol. 2010, 37, 551-561, 10.3892/ijo_00000704
186. Serri, C.; Quagliariello, V.; Iaffaioli, R. V.; Fusco, S.; Botti, G.; Mayol, L.; Biondi, M. Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study. J. Cell. Physiol. 2019, 234, 4959-4969, 10.1002/jcp.27297
187. Nessa, M. U.; Beale, P.; Chan, C.; Yu, J. Q.; Huq, F. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Res. 2011, 31, 3789-3797
188. Lesser, S.; Wolffram, S. Oral bioavailability of the flavonol quercetin-A review. Curr. Top. Nutraceutical Res. 2006, 4, 239-256
189. Singhal, R. L.; Yeh, Y. A.; Praja, N.; Olah, E.; Sledge, G. W., Jr; Weber, G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem. Biophys. Res. Commun. 1995, 208, 425-431, 10.1006/bbrc.1995.1355
190. Staedler, D.; Idrizi, E.; Kenzaoui, B. H.; Juillerat-Jeanneret, L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother. Pharmacol. 2011, 68, 1161-1172, 10.1007/s00280-011-1596-x
191. Vidya Priyadarsini, R.; Senthil Murugan, R.; Maitreyi, S.; Ramalingam, K.; Karunagaran, D.; Nagini, S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur. J. Pharmacol. 2010, 649, 84-91, 10.1016/j.ejphar.2010.09.020
192. Calgarotto, A. K.; Maso, V.; Junior, G. C. F.; Nowill, A. E.; Filho, P. L.; Vassallo, J.; Saad, S. T. O. Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells. Sci. Rep. 2018, 8, 3459 10.1038/s41598-018-21516-5
193. Naimi, A.; Entezari, A.; Hagh, M. F.; Hassanzadeh, A.; Saraei, R.; Solali, S. Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis. J. Cell. Physiol. 2019, 234, 13233-13241, 10.1002/jcp.27995
194. Kim, W. K.; Bang, M. H.; Kim, E. S.; Kang, N. E.; Jung, K. C.; Cho, H. J.; Park, J. H. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J. Nutr. Biochem. 2005, 16, 155-162, 10.1016/j.jnutbio.2004.10.010
195. Baron, B. W.; Thirman, M. J.; Giurcanu, M. C.; Baron, J. M. Quercetin Therapy for Selected Patients with PIM1 Kinase-Positive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pilot Study. Acta Haematol. 2018, 139, 132-139, 10.1159/000486361
196. Ranelletti, F. O.; Ricci, R.; Larocca, L. M.; Maggiano, N.; Capelli, A.; Scambia, G.; Benedetti-Panici, P.; Mancuso, S.; Rumi, C.; Piantelli, M. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer 1992, 50, 486-492, 10.1002/ijc.2910500326
197. Ranelletti, F. O.; Maggiano, N.; Serra, F. G.; Ricci, R.; Larocca, L. M.; Lanza, P.; Scambia, G.; Fattorossi, A.; Capelli, A.; Piantelli, M. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int. J. Cancer 2000, 85, 438-445, 10.1002/(SICI)1097-0215(20000201)85:3<438::AID-IJC22>3.0.CO;2-F
198. Yoshida, M.; Sakai, T.; Hosokawa, N.; Marui, N.; Matsumoto, K.; Fujioka, A.; Nishino, H.; Aoike, A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 1990, 260, 10-13, 10.1016/0014-5793(90)80053-L
199. Shang, H. S.; Lu, H. F.; Lee, C. H.; Chiang, H. S.; Chu, Y. L.; Chen, A.; Lin, Y. F.; Chung, J. G. Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ. Toxicol. 2018, 33, 1168-1181, 10.1002/tox.22623
200. 2-Induced Apoptosis of Intestinal Porcine Enterocyte Cells. Molecules 2018, 23, 2012, 10.3390/molecules23082012
201. Chuang, C. H.; Chan, S. T.; Chen, C. H.; Yeh, S. L. Quercetin enhances the antitumor activity of trichostatin A through up-regulation of p300 protein expression in p53 null cancer cells. Chem.-Biol. Interact. 2019, 306, 54-61, 10.1016/j.cbi.2019.04.006
202. Ackland, M. L.; van de Waarsenburg, S.; Jones, R. Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines. In Vivo 2005, 19, 69-76
203. Yalçln, A. S.; Yllmaz, A. M.; Altundaǧ, E. M.; Koçtürk, S. Kurkumin, kuersetin ve çay kateşinlerinin anti-kanser etkileri. Marmara Pharm. J. 2016, 21, 19-29, 10.12991/marupj.259877
204. Vargas, A. J.; Burd, R. Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management. Nutrition reviews 2010, 68, 418-428, 10.1111/j.1753-4887.2010.00301.x
205. Nam, J. S.; Sharma, A. R.; Nguyen, L. T.; Chakraborty, C.; Sharma, G.; Lee, S. S. Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine. Molecules 2016, 21, 108, 10.3390/molecules21010108
206. Aguirre, L.; Arias, N.; Macarulla, M. T.; Gracia, A.; Portillo, M. P. Beneficial effects of quercetin on obesity and diabetes. Open Nutraceuticals J. 2011, 4, 189-198, 10.2174/1876396001104010189
207. Chen, S.; Jiang, H.; Wu, X.; Fang, J. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediators Inflammation 2016, 2016, 9340637 10.1155/2016/9340637
208. Ostadmohammadi, V.; Milajerdi, A.; Ayati, E.; Kolahdooz, F.; Asemi, Z. Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Phytother. Res. 2019, 33, 1330-1340, 10.1002/ptr.6334
209. Chondrogianni, N.; Kapeta, S.; Chinou, I.; Vassilatou, K.; Papassideri, I.; Gonos, E. S. Anti-ageing and rejuvenating effects of quercetin. Exp. Gerontol. 2010, 45, 763-771, 10.1016/j.exger.2010.07.001
210. Geng, L.; Liu, Z.; Zhang, W.; Li, W.; Wu, Z.; Wang, W.; Ren, R.; Su, Y.; Wang, P.; Sun, L.; Ju, Z.; Chan, P.; Song, M.; Qu, J.; Liu, G. H. Chemical screen identifies a geroprotective role of quercetin in premature aging. Protein Cell 2019, 10, 417-435, 10.1007/s13238-018-0567-y
211. Larson, A. J.; Symons, J. D.; Jalili, T. Quercetin: A Treatment for Hypertension?-A Review of Efficacy and Mechanisms. Pharmaceuticals 2010, 3, 237-250, 10.3390/ph3010237
212. Gormaz, J. G.; Quintremil, S.; Rodrigo, R. Cardiovascular Disease: A Target for the Pharmacological Effects of Quercetin. Curr. Top. Med. Chem. 2015, 15, 1735-1742, 10.2174/1568026615666150427124357
213. Khurana, S.; Venkataraman, K.; Hollingsworth, A.; Piche, M.; Tai, T. C. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients 2013, 5, 3779-3827, 10.3390/nu5103779
214. Tribolo, S.; Lodi, F.; Connor, C.; Suri, S.; Wilson, V. G.; Taylor, M. A.; Needs, P. W.; Kroon, P. A.; Hughes, D. A. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 2008, 197, 50-56, 10.1016/j.atherosclerosis.2007.07.040
215. Carrasco-Pozo, C.; Cires, M. J.; Gotteland, M. Quercetin and Epigallocatechin Gallate in the Prevention and Treatment of Obesity: From Molecular to Clinical Studies. J. Med. food 2019, 22, 753-770, 10.1089/jmf.2018.0193
216. Patel, R. V.; Mistry, B. M.; Shinde, S. K.; Syed, R.; Singh, V.; Shin, H. S. Therapeutic potential of quercetin as a cardiovascular agent. Eur. J. Med. Chem. 2018, 155, 889-904, 10.1016/j.ejmech.2018.06.053
217. D'Andrea, G. Quercetin: A flavonol with multifaceted therapeutic applications?. Fitoterapia 2015, 106, 256-271, 10.1016/j.fitote.2015.09.018
218. Boots, A. W.; Haenen, G. R.; Bast, A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585, 325-337, 10.1016/j.ejphar.2008.03.008
219. Kook, D.; Wolf, A. H.; Yu, A. L.; Neubauer, A. S.; Priglinger, S. G.; Kampik, A.; Welge-Lussen, U. C. The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol. Visual Sci. 2008, 49, 1712-1720, 10.1167/iovs.07-0477
220. Suematsu, N.; Hosoda, M.; Fujimori, K. Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells. Neurosci. Lett. 2011, 504, 223-227, 10.1016/j.neulet.2011.09.028
221. Carullo, G.; Cappello, A. R.; Frattaruolo, L.; Badolato, M.; Armentano, B.; Aiello, F. Quercetin and derivatives: useful tools in inflammation and pain management. Future Med. Chem. 2017, 9, 79-93, 10.4155/fmc-2016-0186
222. Gokhale, J. P.; Mahajan, H. S.; Surana, S. J. Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: In vivo and in vitro studies. Biomed. Pharmacother. 2019, 112, 108622 10.1016/j.biopha.2019.108622
223. Dietrich-Muszalska, A.; Olas, B. Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro. World J. Biol. Psychiatry 2010, 11, 276-281, 10.3109/15622970902718790
224. Rabinovich, L.; Kazlouskaya, V. Herbal sun protection agents: Human studies. Clin. Dermatol. 2018, 36, 369-375, 10.1016/j.clindermatol.2018.03.014
225. Gaudry, A.; Bos, S.; Viranaicken, W.; Roche, M.; Krejbich-Trotot, P.; Gadea, G.; Despres, P.; El-Kalamouni, C. The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection in Human Cells. Int. J. Mol. Sci. 2018, 19, 1093, 10.3390/ijms19041093
226. Gargouri, B.; Mansour, R. B.; Abdallah, F. B.; Elfekih, A.; Lassoued, S.; Khaled, H. Protective effect of quercetin against oxidative stress caused by dimethoate in human peripheral blood lymphocytes. Lipids Health Dis. 2011, 10, 149, 10.1186/1476-511X-10-149
227. Choi, M. H.; Shin, H. J. Anti-melanogenesis effect of quercetin. Cosmetics 2016, 3, 18, 10.3390/cosmetics3020018
228. Kawabata, K.; Mukai, R.; Ishisaka, A. Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct. 2015, 6, 1399-1417, 10.1039/C4FO01178C
229. Graefe, E. U.; Wittig, J.; Mueller, S.; Riethling, A.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; H, H. D.; Veit, M. Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans. J. Clin. Psychopharmacol. 2001, 41, 492-499, 10.1177/00912700122010366
230. Almeida, A. F.; Borge, G. I. A.; Piskula, M.; Tudose, A.; Tudoreanu, L.; Valentová, K.; Williamson, G.; Santos, C. N. Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation. Compr. Rev. Food Sci. Food Saf. 2018, 17, 714-731, 10.1111/1541-4337.12342
231. Mukhopadhyay, P.; Prajapati, A. K. Quercetin in anti-diabetic research and strategies for improved quercetin bioavailability using polymer-based carriers-a review. RSC Adv. 2015, 5, 97547-97562, 10.1039/C5RA18896B
232. Rizvi, S. A. A.; Saleh, A. M. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm. J. 2018, 26, 64-70, 10.1016/j.jsps.2017.10.012
233. Baksi, R.; Singh, D. P.; Borse, S. P.; Rana, R.; Sharma, V.; Nivsarkar, M. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles. Biomed. Pharmacother. 2018, 106, 1513-1526, 10.1016/j.biopha.2018.07.106
234. de Oliveira Pedro, R.; Hoffmann, S.; Pereira, S.; Goycoolea, F. M.; Schmitt, C. C.; Neumann, M. G. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. Eur. J. Pharm. Biopharm. 2018, 131, 203-210, 10.1016/j.ejpb.2018.08.009
235. Penalva, R.; Gonzalez-Navarro, C. J.; Gamazo, C.; Esparza, I.; Irache, J. M. Zein nanoparticles for oral delivery of quercetin: Pharmacokinetic studies and preventive anti-inflammatory effects in a mouse model of endotoxemia. Nanomed. Nanotechnol. Biol. Med. 2017, 13, 103-110, 10.1016/j.nano.2016.08.033
236. Halder, A.; Mukherjee, P.; Ghosh, S.; Mandal, S.; Chatterji, U.; Mukherjee, A. Smart PLGA nanoparticles loaded with Quercetin: Cellular uptake and in-vitro anticancer study. Mater. Today: Proc. 2018, 5, 9698-9705, 10.1016/j.matpr.2017.10.156
237. Lou, M.; Zhang, L. N.; Ji, P. G.; Feng, F. Q.; Liu, J. H.; Yang, C.; Li, B. F.; Wang, L. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed. Pharmacother. 2016, 84, 1-9, 10.1016/j.biopha.2016.08.055
238. Chitkara, D.; Nikalaje, S. K.; Mittal, A.; Chand, M.; Kumar, N. Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug Delivery Transl. Res. 2012, 2, 112-123, 10.1007/s13346-012-0063-5
239. Tan, B. J.; Liu, Y.; Chang, K. L.; Lim, B. K.; Chiu, G. N. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int. J. Nanomed. 2012, 7, 651-661, 10.2147/IJN.S26538
240. Zhou, H.; Wang, X. Spectrometric study on the interaction of sodium cholate aggregates with quercetin. Colloids Surf., A 2015, 481, 31-37, 10.1016/j.colsurfa.2015.04.023
241. Sadhukhan, P.; Kundu, M.; Chatterjee, S.; Ghosh, N.; Manna, P.; Das, J.; Sil, P. C. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. Mater. Sci. Eng., C 2019, 100, 129-140, 10.1016/j.msec.2019.02.096
242. Braga, L. R.; Pérez, L. M.; Soazo, M. dV.; Machado, F. Evaluation of the antimicrobial, antioxidant and physicochemical properties of Poly(Vinyl chloride) films containing quercetin and silver nanoparticles. Lwt 2019, 101, 491-498, 10.1016/j.lwt.2018.11.082
243. Yang, X.; Zhang, W.; Zhao, Z.; Li, N.; Mou, Z.; Sun, D.; Cai, Y.; Wang, W.; Lin, Y. Quercetin loading CdSe/ZnS nanoparticles as efficient antibacterial and anticancer materials. J. Inorg. Biochem. 2017, 167, 36-48, 10.1016/j.jinorgbio.2016.11.023
244. Lee, G. H.; Lee, S. J.; Jeong, S. W.; Kim, H. C.; Park, G. Y.; Lee, S. G.; Choi, J. H. Antioxidative and antiinflammatory activities of quercetin-loaded silica nanoparticles. Colloids Surf., B 2016, 143, 511-517, 10.1016/j.colsurfb.2016.03.060
245. Aghapour, F.; Moghadamnia, A. A.; Nicolini, A.; Kani, S. N. M.; Barari, L.; Morakabati, P.; Rezazadeh, L.; Kazemi, S. Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem. Biophys. Res. Commun. 2018, 500, 860-865, 10.1016/j.bbrc.2018.04.174
246. Niazvand, F.; Orazizadeh, M.; Khorsandi, L.; Abbaspour, M.; Mansouri, E.; Khodadadi, A. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina 2019, 55, 114, 10.3390/medicina55040114
247. Hatahet, T.; Morille, M.; Hommoss, A.; Devoisselle, J. M.; Muller, R. H.; Begu, S. Liposomes, lipid nanocapsules and smartCrystals(R): A comparative study for an effective quercetin delivery to the skin. Int. J. Pharm. 2018, 542, 176-185, 10.1016/j.ijpharm.2018.03.019
248. Vijayakumar, A.; Baskaran, R.; Jang, Y. S.; Oh, S. H.; Yoo, B. K. Quercetin-Loaded Solid Lipid Nanoparticle Dispersion with Improved Physicochemical Properties and Cellular Uptake. AAPS PharmSciTech 2017, 18, 875-883, 10.1208/s12249-016-0573-4
249. Liu, L.; Tang, Y.; Gao, C.; Li, Y.; Chen, S.; Xiong, T.; Li, J.; Du, M.; Gong, Z.; Chen, H.; Liu, L.; Yao, P. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf., B 2014, 115, 125-131, 10.1016/j.colsurfb.2013.11.029
250. Srinivas, K.; King, J. W.; Howard, L. R.; Monrad, J. K. Solubility and solution thermodynamic properties of quercetin and quercetin dihydrate in subcritical water. J. Food Eng. 2010, 100, 208-218, 10.1016/j.jfoodeng.2010.04.001
251. Biasutto, L.; Marotta, E.; Garbisa, S.; Zoratti, M.; Paradisi, C. Determination of quercetin and resveratrol in whole blood - implications for bioavailability studies. Molecules 2010, 15, 6570-6579, 10.3390/molecules15096570
252. Kumari, A.; Kumar, V.; Yadav, S. K. Plant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approach. PLoS One 2012, 7, e41230 10.1371/journal.pone.0041230
253. Souza, M. P.; Vaz, A. F. M.; Correia, M. T. S.; Cerqueira, M. A.; Vicente, A. A.; Carneiro-da-Cunha, M. G. Quercetin-loaded lecithin/chitosan nanoparticles for functional food applications. Food Bioprocess Technol. 2014, 7, 1149-1159, 10.1007/s11947-013-1160-2
254. Gugler, R.; Leschik, M.; Dengler, H. J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975, 9, 229-234, 10.1007/BF00614022
255. Lipinski, C. A. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technol. 2004, 1, 337-341, 10.1016/j.ddtec.2004.11.007
256. Kawai, Y. Understanding metabolic conversions and molecular actions of flavonoids in vivo:toward new strategies for effective utilization of natural polyphenols in human health. J. Med. Invest. 2018, 65, 162-165, 10.2152/jmi.65.162
257. de Boer, V. C.; Dihal, A. A.; van der Woude, H.; Arts, I. C.; Wolffram, S.; Alink, G. M.; Rietjens, I. M.; Keijer, J.; Hollman, P. C. Tissue distribution of quercetin in rats and pigs. J. Nutr. 2005, 135, 1718-1725, 10.1093/jn/135.7.1718
258. Olthof, M. R.; Hollman, P. C.; Vree, T. B.; Katan, M. B. Bioavailabilities of quercetin-3-glucoside and quercetin-4′-glucoside do not differ in humans. J. Nutr. 2000, 130, 1200-1203, 10.1093/jn/130.5.1200
259. Stopa, J. D.; Neuberg, D.; Puligandla, M.; Furie, B.; Flaumenhaft, R.; Zwicker, J. I. Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. JCI insight 2017, 2, e89373 10.1172/jci.insight.89373
260. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Res. 2001, 35, 941-952, 10.1080/10715760100301441
261. Hollman, P. C. H.; Arts, I. C. W. Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agric. 2000, 80, 1081-1093, 10.1002/(SICI)1097-0010(20000515)80:7<1081::AID-JSFA566>3.0.CO;2-G
262. Manach, C.; Donovan, J. L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radical Res. 2004, 38, 771-785, 10.1080/10715760410001727858
263. Li, W.; Yi, S.; Wang, Z.; Chen, S.; Xin, S.; Xie, J.; Zhao, C. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies. Int. J. Pharm. 2011, 420, 161-171, 10.1016/j.ijpharm.2011.08.024
264. Sarkar, S.; Mandal, S.; Sinha, J.; Mukhopadhyay, S.; Das, N.; Basu, M. K. Quercetin: critical evaluation as an antileishmanial agent in vivo in hamsters using different vesicular delivery modes. J. Drug Targeting 2002, 10, 573-578, 10.1080/106118021000072681
265. Li, H.; Zhao, X.; Ma, Y.; Zhai, G.; Li, L.; Lou, H. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Controlled Release 2009, 133, 238-244, 10.1016/j.jconrel.2008.10.002
266. Ghosh, D.; Ghosh, S.; Sarkar, S.; Ghosh, A.; Das, N.; Das Saha, K.; Mandal, A. K. Quercetin in vesicular delivery systems: evaluation in combating arsenic-induced acute liver toxicity associated gene expression in rat model. Chem.-Biol. Interact. 2010, 186, 61-71, 10.1016/j.cbi.2010.03.048
267. Chakraborty, S.; Stalin, S.; Das, N.; Choudhury, S. T.; Ghosh, S.; Swarnakar, S. The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials 2012, 33, 2991-3001, 10.1016/j.biomaterials.2011.12.037
268. Ghosh, S.; Sarkar, S.; Choudhury, S. T.; Ghosh, T.; Das, N. Triphenyl phosphonium coated nano-quercetin for oral delivery: Neuroprotective effects in attenuating age related global moderate cerebral ischemia reperfusion injury in rats. Nanomed. Nanotechnol. Biol. Med. 2017, 13, 2439-2450, 10.1016/j.nano.2017.08.002
269. Sousa-Batista, A. J.; Poletto, F. S.; Philipon, C.; Guterres, S. S.; Pohlmann, A. R.; Rossi-Bergmann, B. Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis. Parasitology 2017, 144, 1769-1774, 10.1017/S003118201700097X
270. Tian, F.; Dahmani, F. Z.; Qiao, J.; Ni, J.; Xiong, H.; Liu, T.; Zhou, J.; Yao, J. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Acta Biomater. 2018, 75, 398-412, 10.1016/j.actbio.2018.05.050
271. Saha, C.; Kaushik, A.; Das, A.; Pal, S.; Majumder, D. Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment. PLoS One 2016, 11, e0155710 10.1371/journal.pone.0155710
272. Minaei, A.; Sabzichi, M.; Ramezani, F.; Hamishehkar, H.; Samadi, N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol. Biol. Rep. 2016, 43, 99-105, 10.1007/s11033-016-3942-x
273. Zhang, Z.; Xu, S.; Wang, Y.; Yu, Y.; Li, F.; Zhu, H.; Shen, Y.; Huang, S.; Guo, S. Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells. J. Colloid Interface Sci. 2018, 509, 47-57, 10.1016/j.jcis.2017.08.097
274. Zhu, B.; Yu, L.; Yue, Q. Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy. Biomed. Pharmacother. 2017, 91, 287-294, 10.1016/j.biopha.2017.02.112
275. Rezvani, M.; Mohammadnejad, J.; Narmani, A.; Bidaki, K. Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system. Int. J. Biol. Macromol. 2018, 113, 1287-1293, 10.1016/j.ijbiomac.2018.02.141
276. Mu, Y.; Fu, Y.; Li, J.; Yu, X.; Li, Y.; Wang, Y.; Wu, X.; Zhang, K.; Kong, M.; Feng, C.; Chen, X. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug. Carbohydr. Polym. 2019, 203, 10-18, 10.1016/j.carbpol.2018.09.020
277. Li, J.; He, Z.; Yu, S.; Li, S.; Ma, Q.; Yu, Y.; Zhang, J.; Li, R.; Zheng, Y.; He, G.; Song, X. Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J. Biomed. Nanotechnol. 2012, 8, 809-817, 10.1166/jbn.2012.1433
278. Gupta, P.; Authimoolam, S. P.; Hilt, J. Z.; Dziubla, T. D. Quercetin conjugated poly(beta-amino esters) nanogels for the treatment of cellular oxidative stress. Acta Biomater. 2015, 27, 194-204, 10.1016/j.actbio.2015.08.039
279. Catauro, M.; Bollino, F.; Nocera, P.; Piccolella, S.; Pacifico, S. Entrapping quercetin in silica/poly(ethylene glycol) hybrid materials: Chemical characterization and biocompatibility. Mater. Sci. Eng., C 2016, 68, 205-212, 10.1016/j.msec.2016.05.082
280. Abd-Rabou, A. A.; Ahmed, H. H. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line. Adv. Med. Sci. 2017, 62, 357-367, 10.1016/j.advms.2017.01.003
281. Das, S.; Roy, P.; Mondal, S.; Bera, T.; Mukherjee, A. One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis. Colloids Surf., B 2013, 107, 27-34, 10.1016/j.colsurfb.2013.01.061
282. Rezaei-Sadabady, R.; Eidi, A.; Zarghami, N.; Barzegar, A. Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes. Artif. Cells, Nanomed., Biotechnol. 2016, 44, 128-134, 10.3109/21691401.2014.926456
283. Huang, X.; Chen, X.; Chen, Q.; Yu, Q.; Sun, D.; Liu, J. Investigation of functional selenium nanoparticles as potent antimicrobial agents against superbugs. Acta Biomater. 2016, 30, 397-407, 10.1016/j.actbio.2015.10.041
284. Kumar, P.; Sharma, G.; Kumar, R.; Singh, B.; Malik, R.; Katare, O. P.; Raza, K. Promises of a biocompatible nanocarrier in improved brain delivery of quercetin: Biochemical, pharmacokinetic and biodistribution evidences. Int. J. Pharm. 2016, 515, 307-314, 10.1016/j.ijpharm.2016.10.024
285. Lozano-Pérez, A. A.; Rivero, H. C.; Perez Hernandez, M. D. C.; Pagan, A.; Montalban, M. G.; Villora, G.; Cenis, J. L. Silk fibroin nanoparticles: Efficient vehicles for the natural antioxidant quercetin. Int. J. Pharm. 2017, 518, 11-19, 10.1016/j.ijpharm.2016.12.046
286. Abd El-Fattah, A. I.; Fathy, M. M.; Ali, Z. Y.; El-Garawany, A. E. A.; Mohamed, E. K. Enhanced therapeutic benefit of quercetin-loaded phytosome nanoparticles in ovariectomized rats. Chem.-Biol. Interact. 2017, 271, 30-38, 10.1016/j.cbi.2017.04.026
287. Singh, J.; Mittal, P.; Vasant Bonde, G.; Ajmal, G.; Mishra, B. Design, optimization, characterization and in-vivo evaluation of Quercetin enveloped Soluplus(R)/P407 micelles in diabetes treatment. Artif. Cells, Nanomed., Biotechnol. 2018, 46, S546-S555, 10.1080/21691401.2018.1501379
288. Habas, K.; Abdulmwli, M.; Demir, E.; Jacob, B. K.; Najafzadeh, M.; Anderson, D. DNA damage protection by bulk and nano forms of quercetin in lymphocytes of patients with chronic obstructive pulmonary disease exposed to the food mutagen 2-amino-3-methylimidazo [4,5-f]quinolone (IQ). Environ. Res. 2018, 166, 10-15, 10.1016/j.envres.2018.05.012